In vitro activity of doxycycline against bacteria from clinical material.
Doxycycline (alpha-6-deoxy-oxytetracycline) was tested against various bacteria of recent clinical origin with 30-mug discs. The antibiotic susceptibility of these bacteria to commonly used antimicrobial agents was also established. Those bacteria which responded with equivocal zones of inhibition about the tetracycline compounds were tested by the tube dilution technique. Staphylococci and enterococci consistently displayed greater in vitro susceptibility to doxycycline than to tetracycline or demethylchlortetracycline.
D000667:Ampicillin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D002512:Cephalothin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D007709:Klebsiella / Q000187:drug effects; D008034:Lincomycin / Q000494:pharmacology; D008712:Methicillin / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D009827:Oleandomycin / Q000494:pharmacology; D010118:Oxytetracycline / Q000494:pharmacology*; D010406:Penicillins / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D010406:Penicillins; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D008034:Lincomycin; D013752:Tetracycline; D009355:Neomycin; D009827:Oleandomycin; D008712:Methicillin; D002512:Cephalothin; D010118:Oxytetracycline; D013307:Streptomycin